We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Carboplatin injection, USP 450mg/45mL (10mg/mL) multiple-dose vial (Ingenus, USA)
Section 19A approved medicine
(Approval lapsed) Carboplatin injection, USP 450mg/45mL (10mg/mL) multiple-dose vial (Ingenus, USA)
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Expired
Medicines in short supply/unavailable
CARBOPLATIN ACCORD carboplatin 450 mg/45 mL solution for injection vial - ARTG 215854
Indication(s)
Advanced stage ovarian cancer of epithelial origin.
Images
